author-photo

J-P Machiels

Cliniques Universitaires Saint-Luc

82

Papers

797

Citations

Citation Trend

Filter By

Papers (57) Sort By

Journal Conference Others

Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.

2021 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Health-Related Quality of Life (HRQoL) in men with metastatic Castration-Resistant Prostate Cancer (mCRPC) receiving Talazoparib (TALA): TALAPRO-1

2021
Show All
- Source
- Cite
- Save
Citations (0)
580P TALAPRO-1: Talazoparib (TALA) monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) - Exploration of non-DDR mutational landscape and potential associations with antitumor activity

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
581P Patient (pt) reported pain in men with metastatic castration-resistant prostate cancer (mCRPC) receiving talazoparib (TALA): TALAPRO-1

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
138P TALAPRO-1: Talazoparib (TALA) monotherapy in men with DNA damage response alterations (DDRalt) and metastatic castration-resistant prostate cancer (mCRPC): Exploration of DDRalt germline/somatic origin

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
609O Results from a phase I study of AMG 160, a half-life extended (HLE), PSMA-targeted, bispecific T-cell engager (BiTE®) immune therapy for metastatic castration-resistant prostate cancer (mCRPC)

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus.

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (90)
Validation of the Correlation Between Single Nucleotide Polymorphism rs307826 in VEGFR3 and Outcome in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Sunitinib

2020
Show All
- Source
- Cite
- Save
Citations (0)
973TiP LEAP-010: Phase III study of first-line pembrolizumab with or without lenvatinib in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)